GIP stimulates glucagon secretion in healthy individuals and those with type 2 diabetes, especially at lower plasma glucose concentrations [34–37], whereas the insulinotropic actions are more prominent during hyperglycaemia [35, 36]. Here, GIP is linked to type 2 diabetes mellitus.